Vise Technologies’s Privia Health PRVA Stock Holding History

Vise Technologies’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$215K	Buy	+10,929	New	+$249K	﹤0.01%	1939

Other funds holding PRVA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Van Berkom & Associates Montreal, Quebec, Canada $2.81B AUM 6.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.41B AUM 6.54% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Vise Technologies's PRVA Position: Q3 2026 in Review

Vise Technologies opened a new position in Privia Health (PRVA) in Q3 2026: 10,929 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #1939 among its holdings.

157 funds tracked by Wall St. Rank hold PRVA as of Q3 2026.

Vise Technologies held 10,929 shares of Privia Health worth $215K as of Q3 2026.
Privia Health was a new Vise Technologies position in Q3 2026.
Privia Health made up ﹤0.01% of Vise Technologies's portfolio in Q3 2026, its #1939 holding.
157 funds tracked by Wall St. Rank held Privia Health as of Q3 2026.

Based on Vise Technologies's 13F filing for Q3 2026, filed 29 Oct 2026.